ULTRA LONG ACTING PHARMACEUTICAL COMPOSITION COMPRISING INSULIN

The present invention discloses a stable ultra long acting injectable solution comprising Insulin glargine, collagen and one or more pharmaceutically acceptable excipients or carrier at pH 2-5. The present invention also discloses the process for preparing the said composition and its use in treatme...

Full description

Saved in:
Bibliographic Details
Main Authors KWON, Hyuk Jin, AVHAD, Satyashila Babaji, KIM, Ga Vin, PENUMAJJI, Soma Sekhar, JUN, Yong Soo, PARK, Ji Hyeong, PATIL, Hemant Ramesh, SAHIB, Maharaj Kishen
Format Patent
LanguageEnglish
French
Published 01.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention discloses a stable ultra long acting injectable solution comprising Insulin glargine, collagen and one or more pharmaceutically acceptable excipients or carrier at pH 2-5. The present invention also discloses the process for preparing the said composition and its use in treatment of metabolic disorders including diabetes mellitus. La présente invention divulgue une solution injectable à action ultra-longue stable comprenant de l'insuline glargine, du collagène et un ou plusieurs excipients pharmaceutiquement acceptables ou une molécule porteuse à un pH de 2 à 5. La présente invention divulgue également le procédé de préparation de ladite composition et son utilisation dans le traitement de troubles métaboliques comprenant le diabète sucré.
Bibliography:Application Number: WO2022KR18645